SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A reported exploit affecting NEAR Intents has prompted concern about cross-chain security and whether users will continue to trust the service. Traders are divided between treating the incident as contained and buying the dip, and worrying it could undermine NEARs adoption narrative.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNBs recent rebound is drawing technical-trading attention, with repeated chart commentary describing consolidation near resistance. Traders are split between expecting further upside and anticipating a pullback after the gains.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares are drawing attention for their prolonged, volatile slide and repeated difficulty holding above the $150 area, with many traders questioning the decline despite citing the companys growth. Debate centers on insider selling and a lack of clarity around AI data-licensing deals, while bulls point to Reddits data value and the Anthropic case as potential positives.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems RAMP 201 molecular-profiling and external-control analyses in recurrent low-grade serous ovarian cancer are drawing attention, with traders debating whether activity in KRAS wild-type patients could broaden the treatment opportunity. The discussion also looks ahead to VS-7375 clinical data, while some investors question why the positive developments have not translated into a stronger share price.

Pump.fun

PUMPs rebound is drawing bullish attention, with traders pointing to the tokens revenue-funded buybacks and burns and renewed activity across Solanas memecoin ecosystem. Others remain skeptical, questioning the rallys staying power and describing the token as prone to sharp selloffs.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Reports that OpenAIs latest ultrafast tier is using Nvidia GPUs rather than Cerebras hardware, combined with staged insider-share unlocks, have fueled concern about competition and selling pressure. Traders debate whether the report threatens Cerebras OpenAI relationshipSam Altman has described the companies as close partnerswhile bulls point to AI-inference demand and speculate on a rebound or short squeeze.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss BOT+BAL ovarian-cancer update, reporting an estimated 48% three-year survival in a heavily pretreated trial cohort, is driving attention. Many traders view the durability as encouraging and discuss possible FDA interest, while others caution that the Phase 1b results come from a small, nonrandomized study; debate also centers on dilution and the companys execution history.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRK is drawing attention after a sharp, high-volume rebound, with traders connecting the move to Starknets privacy and Bitcoin DeFi push, including strkBTC and STRK20, as well as its post-quantum security narrative. Bulls point to new capabilities and ecosystem activity, while skeptics remain concerned about token unlocks and the tokens weak longer-term price performance.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figmas sharp swings are fueling debate over whether strong growth, raised guidance and paid AI-feature adoption can outweigh concerns about AI competition, rising costs and selling from unlocked insider shares. Bulls also point to declining short interest and possible short-covering, while bears view the stocks volatility and continued selling pressure as signs of further weakness.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives proposed supply-squeeze upgrade, which traders say could increase token burns and deflation if approved, is fueling bullish accumulation alongside discussion of staking and the networks RWA and institutional-finance activity. Sentiment is sharply divided: some see a contrarian opportunity after a prolonged decline, while others remain skeptical and complain about heavy meme-coin promotion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Meritage (MTH) Down 0.4% Since Last Earnings Report: Can It Rebound?

Meritage (MTH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Compared to Estimates, Meritage (MTH) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Meritage (MTH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Meritage Homes (MTH) Surpasses Q2 Earnings Estimates

Meritage (MTH) delivered earnings and revenue surprises of +9.23% and -1.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Century Communities (CCS) Beats Q2 Earnings and Revenue Estimates

Century Communities (CCS) delivered earnings and revenue surprises of +106.35% and +9.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

MTH or NVR: Which Is the Better Value Stock Right Now?

MTH vs. NVR: Which Stock Is the Better Value Option?

Landmark Housing Affordability Bill Becomes Law: ETFs in Focus

The new U.S. housing law could boost homebuilding and housing stocks, putting homebuilder ETFs like ITB and XHB in focus.



Frontdoor Names Finance and Real Estate Executive Hilla Sferruzza to Board of Directors

Frontdoor, Inc. (NASDAQ: FTDR), the nations leading provider of home warranties and new home builder warranties, today announced that it expanded its board to nine and unanimously approved the election of Hilla Sferruzza as a director, effective today. Sferruzza will also serve on the Audit...

New Strong Sell Stocks for June 24th

CWCO, GSL and MTH have been added to the Zacks Rank #5 (Strong Sell) List on June 24th, 2026.

Dream Finders Homes Appoints Clint Szubinski as Chief Operating Officer

Dream Finders Homes, Inc. (Dream Finders Homes, DFH, the Company) (NYSE: DFH), the 2025 National Builder of the Year, today announced the appointment of Clint Szubinski as Chief Operating Officer (COO). Mr. Szubinski, a seasoned executive with more than two decades of homebuilding leadership...

Why Is Meritage (MTH) Down 8.6% Since Last Earnings Report?

Meritage Homes Corp. engages in the design and construction of single-family attached and detached homes. It operates through the following segments: Homebuilding and Financial Services. The Homebuilding segment acquires and develops land, constructs homes, markets and sells those homes, and provides warranty and customer services. The Financial Services segment offers title and escrows, mortgage, and insurance services. The company was founded by Steven J. Hilton and William W. Cleverly in 1985 and is headquartered in Scottsdale, AZ.

Meritage Homes Corp.

Neutral Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

Current Price	$63.85
Prev Close	$64.37
Open	$66.18
Dividend Yield	2.61%
50-Day Moving Average	$68.92
Beta	1.02
Avg. Volume	880,633.27
PE Ratio	13.34

52-Week High	$85.38
52-Week Low	$58.03
Market Capitalization	$4.16B
EPS (Annual)	$6.35
Price to Book	0.82
Revenue Per Employee	$3.15M

Feed

News

Sentiment

Earnings

Fundamentals

Info

MTH Fundamentals